Dr. Mohammed Barigou - Aman Hospital Qatar

Dr. Mohammed Barigou

Primary SpecialtyEndocrinology Diabetes and Metabolism
TitleConsultant Endocrinologist
DepartmentEndocrinology
LanguagesArabic, English, French
Emailm.barigou@amanhospital.org
Phone+974 4400 4400

Scope of Practice

  • Adrenal, Pituitary, Thyroid and Parathyroid Disorders,
  • Cardiometabolic Risk Reduction and cardiovascular prevention programs
  • Diabetes (Type 1, Type 2, LADA, MODY) and Prediabetes
  • Endocrine Hypertension and adrenal Neoplasia
  • Lipid Disorders and Familial Hypercholesterolemia
  • Non-alcoholic Fatty Liver Disease / MASLD / MASH
  • Obesity, Metabolic Syndrome and Polycystic Ovary Syndrome (PCOS),
  • Rare Endocrine and Metabolic Diseases
Highlights
Academic Achievements
23
Publications
33
Confeence Abstracts
5
Thesis Supervisions
3
Others: National and International Board Certifications
4
Certifications in domains of expertise

Health Care Profession Achievements

  • Former Senior Consultant & Section Head of Lipid Nutrition and Metabolism Consultation at The Endocrinology Division of Lausanne University Hospital (CHUV), Switzerland (2018-2024):
  • Developed multidisciplinary management programs on emerging metabolic risk factors such as MASLD, prediabetes and lipid disorders
  • Certified the EAS Familial Hypercholesterolemia Clinic as part of European FH Network
  • Coordinated the Adrenal Orphanet Rare Endocrine Disorders Center at Lausanne University Hospital
  • Conducted advanced clinical research on endocrine hypertension, metabolic diseases, obesity and dyslipidemia

Experience & Education

  • 2018–2024: Senior Physician Endocrinologist and Section Head at Endocrinology Division of Lausanne University Hospital (CHUV), Switzerland
  • 2016–2018: Consultant in Endocrinology, Diabetes & Hypertension, Paris Greater Hospitals (AP-HP), France:
  • • Endocrinology & Nutrition Department - Ambroise Paré University Hospital
  • • Hypertension & Clinical Investigation Centre - Georges Pompidou Hospital
  • 2012–2016: Endocrinology Diabetes and Metabolism Resident, Toulouse University Hospital, France
  • 2016: French Medical Specialist Degree in Endocrinology Diabetes and Metabolism, Toulouse University, France
  • Thesis: Hyperinsulinemic Hypoglycemia Diagnosis in Gastric Bypass Patients. 2012–2016: Resident in Endocrinology Diabetes and Metabolism, Toulouse University, France
  • 2011: French National Medical Specialty Entrance Examination (Final Rank: 9)
  • 2010 – 2012: Resident in Medicine, Oran University Hospital, Algeria
  • 2009 – 2010: Medical Intern, Oran University Hospital, Algeria
  • 2003-2010: Doctorate in Medicine MD, University of Oran Algeria

Certifications

  • 2025: Certificate of Excellence in Lipidology, European Atherosclerosis Society
  • 2018: European Board Certification in Endocrinology Diabetes and Metabolism, European Union of Medical Specialists (EUMS)
  • 2014: Certificate of Advanced Studies in Endocrine Neoplasia: Paris-Descartes University (France), 2013: Certificate of Advanced Studies in Hypertension & Cardiovascular Risk: Toulouse University
  • Medical Licenses: -Since 2025 QCHP-MOPH Medical License as Consultant Endocrinologist (Qatar) -Since 2018 Swiss Medical License in Endocrinology diabetes and Metabolism (Switzerland)
  • Since 2016: French Medical License in Endocrinology Diabetes and Metabolism (France
  • European Society of Endocrinology (ESE): Full Member and Member of the Young Endocrine Scientist Group (EYES).
  • European Association for the Study of Diabetes (EASD): Full Member
  • European Atherosclerosis Society (EAS) • Full Member and Head of Familial Hypercholesterolemia Clinic (Lausanne, 2020–2024).
  • • Certificate of Excellence in Lipidology from EAS 2025 European Society of Hypertension (ESH):
  • • Full Member since 2015
  • • Fellow of the ESH summer-school 2018

Publications

  • Barigou M, Ramzan I, Chartoumpekis DV. The Role of Aldosterone and the Mineralocorticoid Receptor in Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines. 2025 Jul 22;13(8):1792. doi: 10.3390/biomedicines13081792. PMID: 40868048; PMCID: PMC12383379
  • Tunez K, Ringwald-de Meyer S, Barigou M and Kosinski C, Extreme resistance to subcutaneous insulin in a cirrhotic patient with new-onset diabetes that resolved after transplantation. Front. Endocrinol. 16:1464532. doi: 10.3389/fendo.2025.1464532 https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1464532/full
  • Fatemeh G, Fotsing G, Marques-Vidal P, Kopp P, Barigou M. Predictive value of multiple variable models including nutritional risk score (NRS 2002) on mortality and length of stay of patients with covid-19 infections. The INCOVO study. Clin Nutr ESPEN. 2023 Jun;55:357-363. doi: 10.1016/j.clnesp.2023.04.001. Epub 2023 Apr 11. PMID: 37202068; PMCID: PMC10085867
  • Pinto Almeida M, Fotsing G, Gijs E, Barigou M. Clinical nutrition: what's new in 2022. Rev Med Suisse. 2023 Jan 18;19(N° 809-10):46-51. French. doi: 10.53738/REVMED.2023.19.809-10.46. PMID: 36660837.
  • Tankeu AT, Barigou M, Pedro R, De Micheli R, Bodmer A, Genton L, Collet TH, Tran C. Is ketogenic diet effective against cancer?. Rev Med Suisse. 2023 Mar 22;19(819):576-580. French. doi: 10.53738/REVMED.2023.19.819.576. PMID: 36950789.
  • . Mantziari S, Abboretti F, Favre L, Thomopoulos T, Barigou M, Demartines N, Suter M. Protein malnutrition after Roux-en-Y gastric bypass: a challenging case and scoping review of the literature. Surg Obes Relat Dis. 2022 Dec 28:S1550-7289(22)00828-0. doi: 10.1016/j.soard.2022.12.032. Epub ahead of print. PMID: 36702647.
  • Atallah I, McCormick D, Good JM, Barigou M, Fraga M, Sempoux C, Superti-Furga A, Semple RK, Tran C. Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome. J Clin Lipidol. 2022 Sep-Oct;16(5):583-590. doi: 10.1016/j.jacl.2022.06.004. Epub 2022 Jun 19. PMID: 35780059
  • Kulkarni S, Dominiczak AF, Touyz RM, Spence JD, Batlle D, Barigou M, Brown M, Carey RM, Elijovich F, Taler S, Wilkinson IB. CONNed in Pregnancy. Hypertension.2021 Jun 1: Hypertension.121.17021. Epub ahead of print.
  • Santini S, Suter M, Martinho-Grueber M, Chaubert CM, Barigou M, Favre L, Kopp P, Kouadio A. A Protocol for Rehabilitating the Bypassed Limb Prior to Reversal of Jejunoileal Bypass. Obes Surg. 2021 Jun;31(6):2776-2779
  • Barigou M, Favre L, Fraga M, Artru F. New trends in non-alcoholic fatty liver diseases (NAFLD). Rev Med Suisse. 2020;16(687):586‐591
  • Clark D 3rd, Dominiczak AF, Touyz RM, Barigou M, Zoghby Z, Jones DW. Woman With Polycystic Kidney Disease: The Role of Precision Medicine in Hypertension Management. Hypertension. 2020 Nov; 76(5): 1332-1338.
  • Clark D 3rd, Dominiczak AF, Touyz RM, Barigou M, Zoghby Z, Jones DW. Woman With Polycystic Kidney Disease: The Role of Precision Medicine in Hypertension Management. Hypertension. 2020 Nov; 76(5): 1332-1338.
  • Van Twist DJL, de Leeuw PW, Spiering W, Rossi GP, Dominiczak AF, Jennings GLR, Barigou M, Persu A, Kroon AA. Unifocal and Multifocal Fibromuscular Dysplasia. Hypertension. 2019; 73(1):7‐12.
  • George MJ, Marks DJB, Rezk T, Breckenridge R, Sofat R, Martin J, MacAllister R, Touyz RM, Staessen JA, Bursztyn M, Lappin D, Barigou M, Hingorani A. Resistant Hypertension: Trials and Tribulations. Hypertension. 2018; 71(5):772‐780.
  • Calvet D, Amar L, Rossi GP, Laurent S, Dominiczak AF, Turc G, Barigou M, Jennings G, Guzik T, Touyz RM. Case of Asymptomatic Carotid Artery Stenosis in a Hypertensive Patient. Hypertension. 2017;69(6):985‐991.
  • Amar L, Sharabi Y, Rossi GP, Vidal-Petiot E, Dominiczak AF, Mulatero P, Faucon AL, Dhaun N, Barigou M, Lorthioir A. Case of Primary Aldosteronism With Discordant Hormonal and Computed Tomographic Findings. Hypertension. 2017;69(4):529‐535.
  • . Noilhan C, Barigou M, Bieler L, Amar J, Chamontin B, Bouhanick B. Causes of secondary hypertension in the young population: A monocentric study. Ann Cardiol Angeiol. 2016;65(3):159‐164
  • Barigou M, Ah-Kang F, Orloff E, Amar J, Chamontin B, Bouhanick B. Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension. Ann Cardiol Angeiol. 2015;64(3):169‐174.
  • Ritz P, Vaurs C, Barigou M, Hanaire H. Hypoglycaemia after gastric bypass: mechanisms and treatment. Diabetes Obes Metab. 2016;18(3):217‐223.
  • Barigou M, Garnier C, Debard A, et al. Favorable outcome of severe human herpes virus-6 encephalitis in an HIV-infected patient. AIDS. 2016;30(3):532‐534.
  • Barigou M, Cavalie L, Daviller B, et al. Isolation on chocolate agar culture of legionella pneumophila isolates from subcutaneous abscesses in an immunocompromised patient. J Clin Microbiol. 2015;53(11):3683‐3685.
  • Ritz P, Vaurs C, Barigou M, Hanaire H: Hypoglycémie après bypass gastrique : mise au point. Médecine des Maladies Métaboliques 2015; 9(5):482-487.
  • Bouhanick B, Barigou M, Kantambadouno JB, Chamontin B. Contrôle glycémique et complications liées au diabète : que faut-il en penser ? Épidémiologie, données des principaux essais cliniques et méta-analyses. Presse Med. 2013;42(5):849‐854.
Give us a call

Available from 9am to 8pm, Monday to Friday.

Send us a message

Send your message any time you want.

Our usual reply time: 1 Business day
This site is registered onpixfort.comas a Staging site. Switch to a live site activation to remove this banner.
Learn how to migrate to live site
Secret Link
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.